Skip to main content
. 2024 May 30;98(7):e00066-24. doi: 10.1128/jvi.00066-24

Fig 5.

Fig 5

(A and B) There was no statistically significant difference in the number of SARS-CoV-2 antigen-positive cells in the lungs of (A and C) C57BL/6J or (B and D) 129S mice, between mice that received placebo versus olcegepant pellets at 3 dpi. (C and D) Representative SARS-CoV-2 immunostaining is shown for 3 dpi lung issues from C57B6/J (C) and 129S (D) mice. The scale bar is 100 μm.